30 Years of Evidence

Single fraction radiosurgery for the treatment of renal tumors

Staehler M, Bader M, Schlenker B, Casuscelli J, Karl A, Roosen A, Stief CG, Bex A, Wowra B, Muacevic A | J Urol | 2015

Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma

Ponsky L, Lo SS, Zhang Y, Schluchter M, Liu Y, Patel R, Abouassaly R, Welford S, Gulani V, Haaga JR, Machtay M, Ellis RJ | Radiother Oncol | 2015

Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma

S Kaidar-Person O, Price A, Schreiber E, Zagar TM, Chen RC | Clin Genitourin Cancer | 2017

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

Senger C, Conti A, Kluge A, Pasemann D, Kufeld M, Acker G, Lukas M, Grün A, Kalinauskaite G, Budach V, Waiser J, Stromberger C | BMC Urol | 2019

Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological Outcomes

Michael Staehler, Tina Schuler, Annabel Spek, Severin Rodler, Alexander Tamalunas, Christoph Fürweger, Alexander Muacevic | Cureus | 2022

Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis

Felix Ehret, David Kaul, Markus Kufeld, Clara Vom Endt, Volker Budach, Carolin Senger , Christoph Fürweger , Alfred Haidenberger , Alexander Muacevic | J Cancer Res Clin Oncol | 2022

Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer

Dagoglu N, Callery M, Moser J, Tseng J, Kent T, Bullock A, Miksad R, Mancias JD, Mahadevan A | J Cancer | 2016

Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer

Lischalk JW, Burke A, Chew J, Elledge C, Gurka M, Marshall J, Pishvaian M, Collins S, Unger K. | J Gastrointest Cancer | 2018

30 Years of Evidence